α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification
暂无分享,去创建一个
G. Sobue | Y. Hashizume | N. Hishikawa | M. Yoshida | N. Ujihira | Y. Okada
[1] G. Sobue,et al. Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease , 2001, Neuropathology and applied neurobiology.
[2] G. Asano,et al. α-Synuclein-positive structures in cases with sporadic Alzheimer’s disease: morphology and its relationship to tau aggregation , 2001, Brain Research.
[3] T. Iwatsubo,et al. Co-localization of α-synuclein and phosphorylated tau in neuronal and glial cytoplasmic inclusions in a patient with multiple system atrophy of long duration , 2001, Acta Neuropathologica.
[4] S. Terada,et al. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation , 2000, Neuroreport.
[5] K. Arima,et al. NACP/α-synuclein and tau constitute two distinctive subsets of filaments in the same neuronal inclusions in brains from a family of parkinsonism and dementia with Lewy bodies: double-immunolabeling fluorescence and electron microscopic studies , 2000, Acta Neuropathologica.
[6] R. Hamilton,et al. Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.
[7] T. Iwatsubo,et al. α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam , 2000, Journal of neuropathology and experimental neurology.
[8] W. Honer,et al. α‐Synuclein Inclusions in Alzheimer and Lewy Body Diseases , 2000, Journal of neuropathology and experimental neurology.
[9] K. Yang,et al. An Autopsy Case of Pick's Disease. , 2000 .
[10] Kazuko Aoto,et al. Cellular co-localization of phosphorylated tau- and NACP/α-synuclein-epitopes in Lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies , 1999, Brain Research.
[11] P. Højrup,et al. α-Synuclein Binds to Tau and Stimulates the Protein Kinase A-catalyzed Tau Phosphorylation of Serine Residues 262 and 356* , 1999, The Journal of Biological Chemistry.
[12] M. Goedert. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[13] K. Kosaka,et al. Frequent coexistence of Lewy bodies and neurofibrillary tangles in the same neurons of patients with diffuse Lewy body disease , 1999, Neuroscience Letters.
[14] J. Trojanowski,et al. Antibodies to α‐synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease , 1999, Annals of neurology.
[15] J. Hardy,et al. Genetic classification of primary neurodegenerative disease. , 1998, Science.
[16] J Q Trojanowski,et al. Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.
[17] Shigeo Hirai,et al. NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy , 1998, Acta Neuropathologica.
[18] K. Arima,et al. Immunoelectron-microscopic demonstration of NACP/α-synuclein-epitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies , 1998, Brain Research.
[19] B. Winblad,et al. Accumulation of cyclin-dependent kinase 5 (cdk5) in neurons with early stages of Alzheimer's disease neurofibrillary degeneration , 1998, Brain Research.
[20] K. Jellinger,et al. Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia) , 1998, Brain pathology.
[21] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[22] W. Honer,et al. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders. , 1998, The American journal of pathology.
[23] Hitoshi Takahashi,et al. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.
[24] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[25] Y. Hashizume,et al. [An autopsied case of atypical presenile dementia which shows lobar atrophy, severe neurofibrillary tangles and calcification]. , 1997, Rinshō shinkeigaku Clinical neurology.
[26] K. Imahori,et al. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II , 1996, Acta Neuropathologica.
[27] John A. Martin,et al. Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer’s disease and Lewy body disorders , 1996, Acta Neuropathologica.
[28] J. Brion,et al. Cortical and brainstem-type Lewy bodies are immunoreactive for the cyclin-dependent kinase 5. , 1995, The American journal of pathology.
[29] K. Kosaka. Diffuse neurofibrillary tangles with calcification: a new presenile dementia. , 1994, Journal of neurology, neurosurgery, and psychiatry.
[30] H. Iwata,et al. Non-Alzheimer non-Pick dementia with Fahr's syndrome. , 1992, Clinical neuropathology.
[31] H. Ishino,et al. [An autopsy case of Pick's disease with numerous neurofibrillary tangles (author's transl)]. , 1979, Rinshō shinkeigaku Clinical neurology.
[32] A. Siddons. A CASE OF PICK'S DISEASE , 1936 .